» University studies cancer risk and testing for Black women - The Philadelphia Tribune
24/06/19 16:07 from BRCA - Google News
University studies cancer risk and testing for Black women    The Philadelphia Tribune HAMPTON, Va. — Luisel Ricks-Santi keeps the medical family tree of one of the participants in her study taped to the door of her office in h...

» FDA Grants Priority Review to Niraparib for Late-Stage Ovarian Cancer Publish Date - Specialty Pharmacy Times
24/06/19 13:40 from BRCA - Google News
FDA Grants Priority Review to Niraparib for Late-Stage Ovarian Cancer Publish Date    Specialty Pharmacy Times The supplemental New Drug Application supports the expansion of niraparib's indication as a late-line therapeutic op...

» FDA Grants Priority Review to Niraparib for Late-Stage Ovarian Cancer - Specialty Pharmacy Times
24/06/19 13:40 from BRCA - Google News
FDA Grants Priority Review to Niraparib for Late-Stage Ovarian Cancer    Specialty Pharmacy Times Officials with the FDA have granted priority review to a supplemental New Drug Application (sNDA) for niraparib (Zejula) for the ...

» Pfizer's Talzenna To Compete With AZ's Lynparza In Breast Cancer After EU Okay - Scrip
24/06/19 11:45 from BRCA - Google News
Pfizer's Talzenna To Compete With AZ's Lynparza In Breast Cancer After EU Okay    Scrip European approval for its PARP inhibitor to treat BRCA-mutated breast cancer is clearly good news for the US giant but Talzenna will likely...

» FDA accepts Glaxo's application for expanded use of Zejula - Seeking Alpha
24/06/19 08:50 from BRCA - Google News
FDA accepts Glaxo's application for expanded use of Zejula    Seeking Alpha GlaxoSmithKline (GSK) announces that the FDA has accepted under Priority Review TESARO's supplemental marketing application seeking approval to use ...

» Pfizer's Talzenna Gets Approval in Europe for Breast Cancer - Yahoo Finance
24/06/19 08:33 from BRCA - Google News
Pfizer's Talzenna Gets Approval in Europe for Breast Cancer    Yahoo Finance Pfizer Inc. PFE announced that the European Commission has approved its PARP inhibitor, Talzenna (talazoparib) for BRCA-mutated advanced breast cancer...

» Changes in Taste and Food Preferences in Breast Cancer Patients Receiving Chemotherapy: A Pilot Study - DocWire News
24/06/19 08:21 from BRCA - Google News
Changes in Taste and Food Preferences in Breast Cancer Patients Receiving Chemotherapy: A Pilot Study    DocWire News Cancer treatment may relate to appetite reduction and malnutrition. We investigated taste alterations and dis...

» Can BRCA-Positive Patients With Breast Cancer Safely Become Pregnant? - Cancer Therapy Advisor
24/06/19 05:00 from BRCA - Google News
Can BRCA-Positive Patients With Breast Cancer Safely Become Pregnant?    Cancer Therapy Advisor Patients with breast cancer with mutated BRCA may safely become pregnant, according to a study that was presented at the 2019 Ameri...

» New Treatments Combat Rising Mortality Rates in Pancreatic Cancer - www.oncnursingnews.com/
23/06/19 15:20 from BRCA - Google News
New Treatments Combat Rising Mortality Rates in Pancreatic Cancer    www.oncnursingnews.com/ Pancreatic cancer mortality is on the rise compared with other gastrointestinal malignancies, spurring an abundance of novel treatment...

» University studies cancer risk and testing for black women - GoDanRiver.com
23/06/19 09:00 from BRCA - Google News
University studies cancer risk and testing for black women    GoDanRiver.com HAMPTON, Va. (AP) — Luisel Ricks-Santi keeps the medical family tree of one of the participants in her study taped to the door of her office in her la...

Powered by Feed Informer